Contribution of Notch signaling activation to human glioblastoma multiforme

Masayuki Kanamori, Tomohiro Kawaguchi, Janice M. Nigro, Burt G.F. Feuerstein, Mitchel S. Berger, Lucio Miele, Russell O. Pieper

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Object. Because activation of Notch receptors has been suggested to be critical for Ras-mediated transformation, and because many gliomas exhibit deregulated Ras signaling, the authors measured Notch levels and activation in primary samples and cell lines derived from glioblastoma multiforme (GBM) as well as the contribution of Notch pathway activation to astrocytic transformation and growth. Methods. Western blot analysis of Notch 1 expression and activation showed that Notch 1 protein was overexpressed and/or activated in Ras-transformed astrocytes, in three of four GBM cell lines, and in four of five primary GBM samples. Expansion of these studies to assess mRNA expression of components of the Notch signaling pathway by cDNA expression array showed that cDNAs encoding components of the Notch signaling pathway, including the Notch ligand Jagged-1, Notch 3, and the downstream targets of Notch (HES1 and HES2), were also overexpressed relative to nonneoplastic brain controls in 23, 71, and 51% of 35 primary GBMs, respectively. Furthermore, inhibition of Notch signaling by genetic or pharmacological means led to selective suppression of the growth and expression of markers of differentiation in cells exhibiting Notch pathway deregulation. Conclusions. Notch activation contributes to Ras-induced transformation of glial cells and to glioma growth, survival, or both and as such may represent a new target for GBM therapy.

Original languageEnglish (US)
Pages (from-to)417-427
Number of pages11
JournalJournal of Neurosurgery
Volume106
Issue number3
DOIs
StatePublished - Mar 2007
Externally publishedYes

Fingerprint

Glioblastoma
Notch Receptors
Glioma
Growth
Cell Line
Differentiation Antigens
Oligonucleotide Array Sequence Analysis
Neuroglia
Astrocytes
Cell Differentiation
Complementary DNA
Western Blotting
Pharmacology
Ligands
Messenger RNA
Survival
Brain
Therapeutics

Keywords

  • Differentiation
  • Glial cell
  • Glioblastoma multiforme
  • Notch 1
  • Notch pathway

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Kanamori, M., Kawaguchi, T., Nigro, J. M., Feuerstein, B. G. F., Berger, M. S., Miele, L., & Pieper, R. O. (2007). Contribution of Notch signaling activation to human glioblastoma multiforme. Journal of Neurosurgery, 106(3), 417-427. https://doi.org/10.3171/jns.2007.106.3.417

Contribution of Notch signaling activation to human glioblastoma multiforme. / Kanamori, Masayuki; Kawaguchi, Tomohiro; Nigro, Janice M.; Feuerstein, Burt G.F.; Berger, Mitchel S.; Miele, Lucio; Pieper, Russell O.

In: Journal of Neurosurgery, Vol. 106, No. 3, 03.2007, p. 417-427.

Research output: Contribution to journalArticle

Kanamori, M, Kawaguchi, T, Nigro, JM, Feuerstein, BGF, Berger, MS, Miele, L & Pieper, RO 2007, 'Contribution of Notch signaling activation to human glioblastoma multiforme', Journal of Neurosurgery, vol. 106, no. 3, pp. 417-427. https://doi.org/10.3171/jns.2007.106.3.417
Kanamori, Masayuki ; Kawaguchi, Tomohiro ; Nigro, Janice M. ; Feuerstein, Burt G.F. ; Berger, Mitchel S. ; Miele, Lucio ; Pieper, Russell O. / Contribution of Notch signaling activation to human glioblastoma multiforme. In: Journal of Neurosurgery. 2007 ; Vol. 106, No. 3. pp. 417-427.
@article{4d70c283e1a94fd29ed13cec4f9fedcd,
title = "Contribution of Notch signaling activation to human glioblastoma multiforme",
abstract = "Object. Because activation of Notch receptors has been suggested to be critical for Ras-mediated transformation, and because many gliomas exhibit deregulated Ras signaling, the authors measured Notch levels and activation in primary samples and cell lines derived from glioblastoma multiforme (GBM) as well as the contribution of Notch pathway activation to astrocytic transformation and growth. Methods. Western blot analysis of Notch 1 expression and activation showed that Notch 1 protein was overexpressed and/or activated in Ras-transformed astrocytes, in three of four GBM cell lines, and in four of five primary GBM samples. Expansion of these studies to assess mRNA expression of components of the Notch signaling pathway by cDNA expression array showed that cDNAs encoding components of the Notch signaling pathway, including the Notch ligand Jagged-1, Notch 3, and the downstream targets of Notch (HES1 and HES2), were also overexpressed relative to nonneoplastic brain controls in 23, 71, and 51{\%} of 35 primary GBMs, respectively. Furthermore, inhibition of Notch signaling by genetic or pharmacological means led to selective suppression of the growth and expression of markers of differentiation in cells exhibiting Notch pathway deregulation. Conclusions. Notch activation contributes to Ras-induced transformation of glial cells and to glioma growth, survival, or both and as such may represent a new target for GBM therapy.",
keywords = "Differentiation, Glial cell, Glioblastoma multiforme, Notch 1, Notch pathway",
author = "Masayuki Kanamori and Tomohiro Kawaguchi and Nigro, {Janice M.} and Feuerstein, {Burt G.F.} and Berger, {Mitchel S.} and Lucio Miele and Pieper, {Russell O.}",
year = "2007",
month = "3",
doi = "10.3171/jns.2007.106.3.417",
language = "English (US)",
volume = "106",
pages = "417--427",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Contribution of Notch signaling activation to human glioblastoma multiforme

AU - Kanamori, Masayuki

AU - Kawaguchi, Tomohiro

AU - Nigro, Janice M.

AU - Feuerstein, Burt G.F.

AU - Berger, Mitchel S.

AU - Miele, Lucio

AU - Pieper, Russell O.

PY - 2007/3

Y1 - 2007/3

N2 - Object. Because activation of Notch receptors has been suggested to be critical for Ras-mediated transformation, and because many gliomas exhibit deregulated Ras signaling, the authors measured Notch levels and activation in primary samples and cell lines derived from glioblastoma multiforme (GBM) as well as the contribution of Notch pathway activation to astrocytic transformation and growth. Methods. Western blot analysis of Notch 1 expression and activation showed that Notch 1 protein was overexpressed and/or activated in Ras-transformed astrocytes, in three of four GBM cell lines, and in four of five primary GBM samples. Expansion of these studies to assess mRNA expression of components of the Notch signaling pathway by cDNA expression array showed that cDNAs encoding components of the Notch signaling pathway, including the Notch ligand Jagged-1, Notch 3, and the downstream targets of Notch (HES1 and HES2), were also overexpressed relative to nonneoplastic brain controls in 23, 71, and 51% of 35 primary GBMs, respectively. Furthermore, inhibition of Notch signaling by genetic or pharmacological means led to selective suppression of the growth and expression of markers of differentiation in cells exhibiting Notch pathway deregulation. Conclusions. Notch activation contributes to Ras-induced transformation of glial cells and to glioma growth, survival, or both and as such may represent a new target for GBM therapy.

AB - Object. Because activation of Notch receptors has been suggested to be critical for Ras-mediated transformation, and because many gliomas exhibit deregulated Ras signaling, the authors measured Notch levels and activation in primary samples and cell lines derived from glioblastoma multiforme (GBM) as well as the contribution of Notch pathway activation to astrocytic transformation and growth. Methods. Western blot analysis of Notch 1 expression and activation showed that Notch 1 protein was overexpressed and/or activated in Ras-transformed astrocytes, in three of four GBM cell lines, and in four of five primary GBM samples. Expansion of these studies to assess mRNA expression of components of the Notch signaling pathway by cDNA expression array showed that cDNAs encoding components of the Notch signaling pathway, including the Notch ligand Jagged-1, Notch 3, and the downstream targets of Notch (HES1 and HES2), were also overexpressed relative to nonneoplastic brain controls in 23, 71, and 51% of 35 primary GBMs, respectively. Furthermore, inhibition of Notch signaling by genetic or pharmacological means led to selective suppression of the growth and expression of markers of differentiation in cells exhibiting Notch pathway deregulation. Conclusions. Notch activation contributes to Ras-induced transformation of glial cells and to glioma growth, survival, or both and as such may represent a new target for GBM therapy.

KW - Differentiation

KW - Glial cell

KW - Glioblastoma multiforme

KW - Notch 1

KW - Notch pathway

UR - http://www.scopus.com/inward/record.url?scp=33847666952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847666952&partnerID=8YFLogxK

U2 - 10.3171/jns.2007.106.3.417

DO - 10.3171/jns.2007.106.3.417

M3 - Article

VL - 106

SP - 417

EP - 427

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -